Immunosenescence and its role in cancer

Abstract

Abstract: Immunosenescence is a biological process featured by the structural and functional decline of immunity in ageing people, which favors the carcinogenesis by rendering the body′s immune surveillance and tumor escape. Decreasing clearance of tumor cells by macrophages and natural killer cell reflects the immunosenescence of innate immune, also, the tumor antigen presentation ability of dendritic cell is decreased. While, the decline of the CD8+ T cells cytotoxic effect and the secretion of tumor growth factor accounts for the immunosenescence of adaptive immunity. Intervention of immunosenescence may produce the novelty ideas of prevention and treatment of cancer.

Key words: Immunity, Aging, Neoplasms, Immunity, natural, Immunity, maternallyacquired, Tumor escape

TIAN Jian-Hui, LUO Bin, LIU Jia-Xiang. Immunosenescence and its role in cancer[J]. Journal of International Oncology, 2016, 43(2): 122-.

References

［1］ Walford RL. The immunologic theory of aging［J］. Immunological Rev, 1969, 2: 171. DOI:10.1111/j.1600065X.1969.tb00210.x ［2］ Fulop T, Fortin C, Lesur O, et al.The innate immune system and aging:what is the contribution to immunosenescence?［J］. Open Longevity Sci, 2012, 6: 121132. ［3］郭盛淇. 免疫衰老与老年人免疫［J］. 微生物学免疫学进展, 2013, 41(3): 19. ［4］祝丽晶. CD4+CD25+Foxp3+调节性T细胞在衰老过程中的变化及与肺癌的关系探讨［D］ . 苏州: 苏州大学, 2011. ［5］ Kalbasi A, June CH, Haas N, et al. Radiation and immunotherapy: a synergistic combination［J］. J Clin Invest, 2013, 123(7): 27562763. DOI:10.1172/JCI69219. ［6］邢文英, 张娓, 丁一, 等. 不同年龄大鼠免疫器官的衰老细胞［J］. 解剖学杂志, 2006, 29(6): 731733. DOI:10.3969/j.issn.10011633.2006.06.016 ［7］侯茜, 郭美, 张帆. 党参水煎剂对D半乳糖致免疫衰老小鼠胸腺功能的影响［J］. 细胞与分子免疫学杂志, 2014, 30(1): 5557. ［8］ Signer RA, Morrison SJ. Mechanisms that regulate stem cell aging and Life span［J］. Cell Stem Cell, 2013, 12(2): 152165. DOI:10.1016/j.stem.2013.01.001. ［9］ Rodgers JT, Rando TA. Sprouting a new take on stem cell aging［J］. EMBO J, 2012, 31(21): 41034105. DOI:10.1038/emboj.2012.281. ［10］ Djukic M, Nau R, Sieber C. The aging immune system［J］. Dtsch Med Wochenschr, 2014, 139(40): 9871990. DOI:10.1055/s00341370283. ［11］高琦, 马湉, 张霞, 等. CD4+CD25+Foxp3+及CD4+CD25-Foxp3+调节性T细胞在小鼠衰老过程中的变化规律［J］. 山东大学学报: 医学版, 2008, 46(10): 927930. ［12］杜阳阳, 邱玉华, 沈丽琴. FOXP3+Treg在肿瘤患者外周血中的表达及意义［J］. 中国误诊学杂志, 2009, 9(4): 816817. ［13］王会平. 人CD4+CD25+调节性T细胞与免疫衰老及肿瘤之间的关系［D］ . 合肥: 安徽医科大学, 2008. ［14］李彦红, 刘颖, 秦川. 免疫衰老与T、B细胞改变的相关研究［J］. 中国比较医学杂志, 2012, 22(6): 6571. DOI:10.3969/j.issn.16717856.2012.06.015 ［15］杨波, 迟小华, 卢学春, 等. 免疫细胞衰老的研究进展［J］. 中国实验血液学杂志, 2012, 20(3): 782787. ［16］ Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells［J］. Nature, 2009, 457(7229): 557561. DOI:10.1038/nature07665. ［17］王姗, 郑金华, 孟琰, 等. 从细胞因子角度看肿瘤微环境对免疫细胞及肿瘤细胞的影响［J］. 肿瘤学杂志, 2015, 21(3): 237241. ［18］ Goronzy JJ, Li GJ, Yu MC, et al. Signaling pathways in aged T cells  A reflection of T cell differentiation, cell senescence and host environment［J］. Semin Immunol, 2012, 24(5): 365372. DOI:10.1016/j.smim.2012.04.003. ［19］ Larbi A, Pawelec G, Wong SC, et al. Impact of age on T cell signaling: A general defect or specific alterations?［J］. Ageing Res Rev, 2011, 10(3): 370378. DOI:10.1016/j.arr.2010.09.008 . ［20］梁玉杰, 段永强, 成映霞, 等. 衰老进程中机体免疫器官和免疫细胞因子变化及健脾补肾中药的干预研究［J］. 中国中医药信息杂志, 2012, 19(3): 4244. DOI:10.3969/j.issn.10055304.2012.03.016 ［21］杨德洪, 魏勇. 细胞因子Th1/Th2偏移与运动及衰老的关系［J］. 中国组织工程研究与临床康复, 2011, 15(44): 83508354. ［22］ Krasselt M, Baerwald C, Wagner U, et al. CD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence［J］. Arthritis Res Ther, 2013, 15(5): R139. DOI:10.1186/ar4321. ［23］陈万青, 张思维, 曾红梅, 等. 中国2010年恶性肿瘤发病与死亡［J］. 中国肿瘤, 2014, 23(1): 110. DOI:10.11735/j.issn.10040242.2014.01.A001 ［24］ Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014［J］. CA Cancer J Clin, 2014, 64(1): 929. DOI:.10.3322/caac.21208. ［25］ Pan XD, Mao YQ, Zhu LJ, et al. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice［J］. Chin Med J, 2012, 125(11): 20042011. DOI:10.3760/cma.j.issn.03666999.2012.11.030. ［26］ Fessler J, Ficjan A, Duftner C, et al. The impact of aging on regulatory Tcells［J］. Front Immunol, 2013, 4: 231. DOI:10.3389/fimmu.2013.00231. ［27］ De Angulo A, Faris R, Cavazos D, et al. Agerelated alterations in Tlymphocytes modulate key pathways in prostate tumorigenesis［J］. Prostate, 2013, 73(8): 855864. DOI:10.1002/pros.22631. ［28］ Onyema OO, Decoster L, Njemini R, et al. Chemotherapyinduced Changes and Immunosenescence of CD8(+) TCells in Patients with Breast Cancer［J］. Anticancer Res, 2015, 35(3): 14811489. ［29］ Falci C, Gianesin K, Sergi G, et al. Immune senescence and cancer in elderly patients: results from an exploratory study［J］. Exp Gerontol, 2013, 48(12): 14361442. DOI:10.1016/j.exger.2013.09.011. ［30］ VendraminiCosta DB, Carvalho JE. Molecular Link mechanisms between inflammation and cancer［J］. Curr Pharm Des, 2012, 18(26): 38313852. ［31］ De Magalhaes JP. How ageing processes influence cancer［J］. Nat Rev Cancer, 2013, 13(5): 357365. DOI:10.1038/nrc3497. ［32］ Sansoni P, Vescovini R, Fagnoni FF, et al. New advances in CMV and immunosenescence［J］. Exp Gerontol, 2014, 55: 5462. DOI:10.1016/j.exger.2014.03.020. ［33］ Zanussi S, Serraino D, Dolcetti RA, et al. Cancer, aging and immune reconstitution［J］. Anticancer Agents Med Chem, 2013, 13(9): 13101324. ［34］ Hanahan D, Weinberg RA. Hallmarks of cancer: the next Generation［J］. Cell, 2011, 144(5): 646674. DOI:10.1016/j.cell.2011.02.013. ［35］董静懿, 宁小晓, 王蕾, 等. 上海地区健康成年人外周血T淋巴细胞亚群参考区间调查［J］. 检验医学, 2014, 29(6): 617621, 627. ［36］刘嘉湘. 恶性肿瘤的中医药治疗——阴阳平衡与扶正治癌理论在癌症治疗中的应用［J］. 江苏中医药, 2008, 40(9): 12.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.